
    
      Methods: all patients in the study will subject to:

        -  Clinical assessment, WT, Height ,BMI, parity, medications,

        -  DAS 28.

        -  Serum 14-3-3Î· protein.

        -  DEXA scan.

      Grouping:

        -  Group I: RA Patients with low BMD.

        -  Group II: RA Patients with normal BMD.

        -  Group III: normal control.
    
  